NEW YORK, April 7, 2014 /PRNewswire/ --
The trading session on Friday, April 04,
2014 ended on a lower note as the Dow Jones Industrial
Average finished at 16,412.71, down 0.96% and the NASDAQ Composite
closed at 4,127.73, down 2.60%. The S&P 500 finished the
session 1.25% lower at 1,865.09. The losses were broad based as
nine out of ten sectors posted losses. Investor-Edge looks at some
of the equities which attracted the most attention and traded the
most shares during the session. These include The Procter &
Gamble Co. (NYSE: PG), Halozyme Therapeutics Inc. (NASDAQ: HALO),
Symantec Corp. (NASDAQ: SYMC) and IsoRay Inc. (NYSE MKT: ISR). Free
technical research on PG, HALO, SYMC and ISR can be downloaded upon
signing up at:
http://www.investor-edge.com/864-register
Shares in The Procter & Gamble Co. recorded heavy trading as a
total of 8.65 million shares changed hands, against a three-month
average volume of 9.68 million shares. On Friday, the stock
finished the day at $79.77, down
0.41% and at an intraday range of $79.75 and $80.56.
Shares of the company traded at a PE ratio of 19.94. The Procter
& Gamble Co.'s shares have gained 2.19% in the last one month,
while the same has declined 0.71% in the previous three trading
sessions and 2.01% on YTD basis. The S&P 500 Consumer Staples
Sector Index mapped a gain of 0.92% in the last one month, while
the S&P 500 declined 0.69% during the same period. The stock is
trading above its 50-day moving average. The stock has a Relative
Strength Index (RSI) of 54.20. Sign up today to read free research
on PG at:
http://www.investor-edge.com/864-PG-07Apr2014.pdf
On Friday, Halozyme Therapeutics Inc.'s shares recorded heavy
trading as a total of 20.01 million shares changed hands, as
compared with the three-month average volume of 2.15 million
shares. The stock traded at an intraday trading range of
$7.88 and $9.20, before closing the day at $8.43, down 27.26%. Halozyme Therapeutics Inc.'s
shares have fallen by 31.52% in the past three trading sessions,
40.72% in the last one month and 43.76% on YTD basis. The S&P
500 Health Care Sector Index mapped a gain of 4.29% in the previous
three months, while the NASDAQ Composite Index declined 0.61%
during the same period. The stock is trading below its 50-day and
200-day moving averages of $14.15 and
$11.76, respectively. The stock has a
RSI of 19.29. Sign up today to read free research on HALO at:
http://www.investor-edge.com/864-HALO-07Apr2014.pdf
Shares in Symantec Corp. saw heavy trading as a total of 20.17
million shares changed hands, against a three-month average volume
of 9.89 million shares. On Friday, the stock closed the day at
$20.25, up 1.10% and with an intraday
fluctuation between $19.99 and
$20.70. Shares of the company traded
at a PE ratio of 13.84. Symantec Corp.'s shares have advanced 0.35%
in the past three trading sessions, while the stock has declined
2.64% in the last one month and 14.12% on YTD basis. The S&P
500 Information Technology Sector Index fell by 1.78% in the
previous one month, while the NASDAQ Composite Index declined 4.81%
during the same period. The stock is trading below its 50-day and
200-day moving averages of $20.76 and
$23.22, respectively. The company's
shares have an RSI of 50.61. Sign up today to read free research on
SYMC at:
http://www.investor-edge.com/864-SYMC-07Apr2014.pdf
IsoRay Inc.'s shares saw heavy trading as a total of 12.18 million
shares changed hands on Friday, as compared with the three-month
average volume of 7.76 million shares. The stock ended the day at
$3.03, down 1.94%, after trading at
an intraday range of $2.81 and
$3.14. The company's shares have
surged 15.21% in the previous three trading sessions, 267.27% in
the last one month and 506.00% on YTD basis. The S&P 500 Health
Care Sector Index declined 1.46% in the previous three trading
sessions, while the S&P 500 fell by 1.08% during the same
period. The company's shares are trading above their 50-day and
200-day moving averages of $1.27 and
$0.76, respectively. The stock has an
RSI of 69.86. Sign up today to read free research on ISR at:
http://www.investor-edge.com/864-ISR-07Apr2014.pdf
===============
EDITOR'S NOTES:
===============
1. This is not company news. We are an independent source and our
views do not reflect the companies mentioned.
2. Information in this release is fact checked and produced on a
best efforts basis and reviewed by Nidhi Vatsal, a CFA
charterholder. However, we are only human and are prone to make
mistakes. If you notice any errors or omissions, please notify us
below.
3. This information is submitted as a net-positive to companies
mentioned, to increase awareness for mentioned companies to our
subscriber base and the investing public.
4. If you wish to have your company covered in more detail by our
team, or wish to learn more about our services, please contact us
at pubco [at] http://www.investor-edge.com.
5. For any urgent concerns or inquiries, please contact us at
compliance [at] http://www.investor-edge.com.
6. Are you a public company? Would you like to see similar coverage
on your company? Send us a full investors' package to research [at]
http://www.investor-edge.com for consideration.
COMPLIANCE PROCEDURE
Content is researched, written and reviewed on a best-effort basis.
This document, article or report is prepared and authored by
Investor-edge. An outsourced research services provider represented
by Nidhi Vatsal, CFA, has only reviewed the information provided by
Investor-edge in this article or report according to the Procedures
outlined by Investor-edge. Investor-edge is not entitled to veto or
interfere in the application of such procedures by the outsourced
provider to the articles, documents or reports, as the case may
be.
NOT FINANCIAL ADVICE
Investor-edge makes no warranty, expressed or implied, as to the
accuracy or completeness or fitness for a purpose (investment or
otherwise), of the information provided in this document. This
information is not to be construed as personal financial advice.
Readers are encouraged to consult their personal financial advisor
before making any decisions to buy, sell or hold any securities
mentioned herein.
NO WARRANTY OR LIABILITY ASSUMED
Investor-edge is not responsible for any error which may be
occasioned at the time of printing of this document or any error,
mistake or shortcoming. No liability is accepted by Investor-edge
whatsoever for any direct, indirect or consequential loss arising
from the use of this document. Investor-edge expressly disclaims
any fiduciary responsibility or liability for any consequences,
financial or otherwise arising from any reliance placed on the
information in this document. Investor-edge does not (1) guarantee
the accuracy, timeliness, completeness or correct sequencing of the
information, or (2) warrant any results from use of the
information. The included information is subject to change without
notice.
CFA® and Chartered Financial Analyst® are registered trademarks
owned by CFA Institute.
AnalystsReview.com
SOURCE Investor-Edge